INTERNATIONAL PATENT: GENFIT, IPSEN PHARMA FILES APPLICATION FOR "ELAFIBRANOR FOR USE FOR LONG-TERM TREATMENT OF PRIMARY BILIARY CHOLANGITIS"

GENEVA, Oct. 18 -- GENFIT (885 avenue Eugene Avinee59120 LOOS), IPSEN PHARMA (65 quai Georges Gorse92100 Boulogne-Billancourt) filed a patent application (PCT/EP2025/059717) for "ELAFIBRANOR FOR USE FOR LONG-TERM TREATMENT OF PRIMARY BILIARY CHOLANGITIS" on Apr 09, 2025. With publication no. WO/2025/215081, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BIRMAN, Pascal (25 Avenue de Wagram75017 PARIS), ROUDOT, Alice (365, avenue de Dunkerque59160 LOMME), MAGREZ, David (83 avenue Pottier59130 LAMBERSART), MOTTE, Philippe (...